THE CELL CODING COMPANY
LIVE

Serial Number

79293706

Owner

Bit Bio Limited

Attorney

Katrina G. Hull

Filing Date

May 6, 2020

Add to watchlist:

No watchlists yet
View on USPTO

THE CELL CODING COMPANY Trademark

Serial Number: 79293706

THE CELL CODING COMPANY is a trademark filed by Bit Bio Limited on May 6, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 29 (Meats & Processed Foods). The application is currently pending registration.

Owner Contact Info

Bit Bio Limited (21 trademarks)

Pioneer House,
Cambridge, Cambridgeshire CB24 9NL , GB

Entity Type: 99

Trademark Details

Filing Date

May 6, 2020

Registration Date

Not Registered

Goods & Services

Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; genetically or otherwise modified cells for medical, therapeutic or clinical use; cells which are propagated, cultivated and expanded in bioreactors for medical, therapeutic or clinical use; cells for the purpose of tissue regeneration for medical or clinical use; living cells for medical use; cells for medical use; diagnostic preparations for medical and veterinary purposes; cell preparations for drug screening for medical, therapeutic or clinical use; cell preparations for genetic testing, screening for medical, therapeutic or clinical purposes; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical or diagnostic use; tissue culture media, growth factors, and growth media for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells for medical, therapeutic or clinical purposes; cell separation reagents for medical, therapeutic or clinical purposes

Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; biological human tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media for scientific and research use other than for medical or veterinary use; chemical reagents for use in biotechnology, other than for medical or veterinary use; nutritive agents for processing living cells other than for medical use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology other than for medical use other than for medical use; cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical research use; cell preparations for drug screening for research use; genetically or otherwise modified cells for research use; cells which are propagated, cultivated and expanded in bioreactors for research use

Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; bioreactors for biomanufacturing; bioreactors for research use; bioreactor for cell culturing; bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; magnetic cell separation laboratory equipment, namely, apparatus for the separation of cell populations for medical or clinical use

Meat; meat substitutes; tissue engineered meat; synthetic meat; cultured meat; laboratory-grown meat; fish, not live

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, stem cells for scientific purposes, stem cells other than for medical or veterinary purposes, skeletal myocytes for research purposes, cortical neurons for research purposes, biological tissue for research and scientific purposes, biological tissue cultures other than for medical or veterinary purposes, cultures of cell media other than for medical or veterinary use, chemical reagents for use in biotechnology, other than for medical or veterinary use, nutritive agents for processing living cells other than for medical use, semi-processed natural proteins for manufacturing food, proteins for use in the manufacture of food products, proteins for use in recombinant DNA technology other than for medical use, cell therapeutics, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, living cells for medical use, cells for medical use, biological preparations for medical use, diagnostic preparations for medical and veterinary purposes, cell preparations for drug screening, cell preparations for genetic testing, screening, stem cells for medical purposes, stem cells for veterinary purposes, cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, tissue culture media, growth factors, growth media, and serum for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, cell separation reagents, magnetic cell separation equipment, meat, meat substitutes, tissue engineered meat, synthetic meat, cultured meat, laboratory-grown meat and fish, not live

Biotechnology research; scientific testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; stem cell research; synthetic biology services, namely, biological research; stem cell biology services, namely, biological research; scientific services for research, clinical, therapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; research and development in relation to genetic testing, screening; research and development in relation to drug screening; cell separation technology services, namely, research of technology in the field of cell separation; cell separation research services; consultancy relating to biotechnology; scientific and technological consultancy relating to drug screening; scientific and technological consultancy relating to genetic screening; scientific and technological consultancy relating to cell therapy; laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and manufacturing; research on food; research and development in the field of animal cells cultivated within bioreactors; research in the reduction of carbon emissions

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 27, 2026 RCSC
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 8, 2026 ADCH
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 26, 2025 RCSC
NEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2025 NREP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 25, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 24, 2025 RCCK
NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 4, 2024 NREP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 10, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 10, 2024 GNSL
SUSPENSION LETTER WRITTEN
Apr 10, 2024 CNSL
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 27, 2023 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 22, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 21, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 6, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 14, 2022 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 13, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 23, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 23, 2022 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 14, 2021 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 13, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
May 13, 2021 GNSL
SUSPENSION LETTER WRITTEN
May 13, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2021 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2021 TROA
REFUSAL PROCESSED BY IB
Nov 9, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 16, 2020 RFCS
REFUSAL PROCESSED BY MPU
Oct 16, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 24, 2020 RFCR
NON-FINAL ACTION WRITTEN
Sep 23, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 22, 2020 MAFR
ASSIGNED TO EXAMINER
Sep 18, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 17, 2020 REPR